United Therapeutics Corp (UTHR)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$472.50

Buy

$515.20

arrow-up$5.48 (+1.12%)

Prices updated at 13 Dec 2025, 00:00 EST

Prices minimum 15 mins delay

Prices in USD

United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Christopher Patusky,J.D.

CEO

Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

1,305

Head office

1000 Spring Street

Silver Spring

United States

20910

+1 301 608-9292

ir@unither.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Christopher Patusky,J.D. Vice Chairman of the Board and Lead Independent Director	0.14m
Dr. Louis W. Sullivan, M.D. Independent Director	0.09m
Mr. Raymond Dwek,F.R.S. Independent Director	0.08m
Mr. Raymond C. Kurzweil Independent Director	0.06m
Governor Tommy G. Thompson Independent Director	0.08m
Mr. Christopher Causey,M.B.A. Independent Director	0.10m
Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD Chairperson of the Board and Chief Executive Officer	1.51m
Mr. Paul A. Mahon,J.D. Executive Vice President, General Counsel and Corporate Secretary	0.94m
Mr. Richard Giltner Independent Director	0.10m
Dr. Judy D. Olian, PhD Independent Director	0.08m
Mr. James C. Edgemond Chief Financial Officer, Principal Accounting Officer and Treasurer	0.86m
Mr. Michael Benkowitz President and Chief Operating Officer	1.19m
Ms. Nilda Mesa, J.D. Independent Director	0.09m
Dr. Linda Maxwell, M.B.A.,M.D. Independent Director	0.08m
Ms. Jan Malcolm Independent Director	0.03m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	5,352,996
Vanguard Group Inc	4,448,848
BlackRock Fund Advisors	2,833,903
Renaissance Technologies Corp	2,173,392
venBio Select Advisor LLC	2,022,222

Director dealings

Date chevron-l-regular chevron-r-regular	Action
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.